Skip to content

Ultrasound-guided Continuous Proximal Adductor Canal vs Continuous Femoral Nerve Block for Postoperative Pain Control and Rehabilitation Following Total Knee Arthroplasty

Ultrasound-guided Continuous Proximal Adductor Canal Versus Continuous Femoral Nerve Block for Postoperative Pain Control and Rehabilitation Following Total Knee Arthroplasty

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02495805
Enrollment
0
Registered
2015-07-13
Start date
2015-09-30
Completion date
2016-11-30
Last updated
2016-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Knee Arthroplasty

Keywords

a continuous proximal adductor canal block (ACB), continuous femoral nerve block (FNB)

Brief summary

The purpose of the study is to compare continuous femoral nerve block with continuous proximal adductor canal block for postoperative pain control and rehabilitation.

Detailed description

Patients meeting the criteria: American Society of Anesthesiologists (ASA) class I and II, that are scheduled for elective total knee arthroplasty, will be recruited into the study. Subjects will be randomized into 2 groups: those who will receive a continuous proximal adductor canal block (ACB) and those who will receive a continuous femoral nerve block (FNB).

Interventions

Subjects will be randomized into 2 groups: those who will receive a continuous proximal adductor canal block (ACB) and those who will receive a continuous femoral nerve block (FNB).

PROCEDUREContinuous proximal adductor canal block

Subjects will be randomized into 2 groups: those who will receive a continuous proximal adductor canal block (ACB) and those who will receive a continuous femoral nerve block (FNB).

Sponsors

Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients with an American Society of Anesthesiologists Physical Status Classification System (ASA) score of 1 or 2 that are healthy without systemic disease or have mild systemic disease, respectively. * The patient will need to be able to have decision-making capacity and ability to consent for the study.

Exclusion criteria

* Patients with an American Society of Anesthesiologists Physical Status Classification System (ASA) score greater than 2. * Patients unable to have decision-making capacity and ability to consent for the study.

Design outcomes

Primary

MeasureTime frameDescription
Motor effects24 hours (postoperatively)Subjects' change in motor effects will be assessed as maximum voluntary isometric contraction (MVIC) in the quadriceps muscle.

Secondary

MeasureTime frameDescription
Pain scoreOn average between 6 and 8 hours postoperativelySubjects' pain will be assessed using a numerical pain score, where 10 is the greatest amount of pain.
Opioid consumptionOn average between 6 and 8 hours postoperativelySubjects' pain will be assessed by tracking opioid consumption postoperatively.
Motor effectsOn average between 6 and 8 hours postoperativelySubjects' change in motor effects will be assessed as maximum voluntary isometric contraction (MVIC) in the quadriceps muscle.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026